In prostate cancer cells, stimulation with dexamethasone in the presence of enzalutamide resulted in expression of AR target genes63, providing further evidence that GR signaling could compensate for AR in the presence of AR-antagonists. This evidence concerns the gene AR and Familial prostate cancer.